Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.
Vous n'êtes pas connecté
A pivotal study uncovers the molecular signatures of mammographic calcifications in hormone receptor-positive, HER2-negative breast cancer. The research identifies distinct molecular traits associated with calcification status, suggesting that tumours with probably benign calcifications are linked to higher hormone receptor expression and endocrine therapy sensitivity, while tumours with calcifications of high suspicion for malignancy show genomic [...]
Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.
THURSDAY, Sept. 12, 2024 -- The overall second primary malignancy (SPM) point estimate was 5.8 percent for patients receiving chimeric antigen...
Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in...
WEDNESDAY, Sept. 11, 2024 -- Breast arterial calcifications (BAC) identified on mammography are associated with the development of both...
The Menopause Society's 2022 Hormone Therapy Position Statement advises that women aged older than 65 years can continue using hormone therapy (HT)...
The Menopause Society's 2022 Hormone Therapy Position Statement advises that women aged older than 65 years can continue using hormone therapy (HT)...
Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...
Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...
Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c
Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c